Nanotechnology Now

NanoparticleBioChem, Inc

Nanoparticle BioChem Inc. (NBI) is a nanoparticle and specialty biochemical company with focus on applications for human health and hygiene. NBI has made significant progress in developing gold nanoconstructs for both cancer therapy and diagnostics. Animal toxicity trials are now in progress using dogs to evaluate toxicity for a new nanoparticle-based cancer therapy drug. If successful, clinical trials on humans are scheduled to follow in 1 - 2 years. NBI has developed silver nanoparticle-based antimicrobial products that are able to penetrate biofilms and have home and clinical applications. Evaluations by national laboratories show these products to be the most effective agents for use against staph and mold.

In addition to its own research and development activities and product development, NBI develops highest quality nanoparticles and biochemicals for commercial sales to research and development laboratories worldwide through an agreement with a major chemical catalog company and also by direct sales via its website, www.nanoparticlebiocheminc.com. NBI's online catalog lists an array of sizes of gold and silver nanoparticles that are water soluble and highly stable in solution form. Silver nanoparticles are available also in solid form. New products are being added. Individuals who use our products continue to report new and exciting results and applications.

Website

2814 Wild Plum Ct
Columbia, MO 65201 United States
573-639-2619